The North America Leukemia Therapeutics Market is driven by the availability of chemotherapy, targeted therapies, immunotherapies, stem cell transplantation, and other advanced treatment options. The United States remains a major regional contributor, while Canada is also expanding access to innovative leukemia treatments and specialized oncology services. The Leukemia Therapeutics Market was...